Intelligent Bio Solutions Inc. announced on July 23, 2026, that it has resolved all cybersecurity and software-related review items for its upcoming FDA 510(k) submission, following a successful third-party penetration testing. The company is on track to submit its 510(k) notification in the second half of 2026, targeting the U.S. drug screening market. Intelligent Bio Solutions Inc. is a medical technology company delivering intelligent, rapid, non-invasive testing solutions.
